| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -5.43M | 100% | $11.44 | -$62.1M |
| Net | -5 | -5.43M | -100% | -$62.1M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Skorpios Trust | 10%+ Owner | $39.8M | -$53.6M | -57.4% | Jun 4, 2025 |
| Adrian R. Krainer | Director | $9.62M | -$2.29M | -19.3% | Nov 24, 2025 |
| Edward M. MD Kaye | Director | $3.06M | -$3.61M | -54.2% | Oct 8, 2025 |
| Barry Ticho | Chief Medical Officer | $832K | -$1.29M | -60.8% | Nov 3, 2025 |
| Stephen Tulipano | Former CFO | $758K | Mar 27, 2024 | ||
| Huw M. Nash | Chief Business Officer | $631K | Jul 2, 2024 | ||
| Jonathan Allan | General Counsel & Corp Sec | $547K | -$1.28M | -70% | Oct 3, 2025 |
| Levin Arthur A | Director | $520K | Sep 30, 2025 | ||
| Thomas Leggett | Chief Financial Officer | $488K | Mar 20, 2025 | ||
| Jason Hoitt | Chief Patient Officer | $16.1K | Jun 18, 2025 | ||
| Arthur Tzianabos | Interim Executive Chair, Director | Mar 20, 2025 | |||
| Ian F. Smith | Chief Executive Officer, Director | Oct 8, 2025 | |||
| Julie Smith | Director | Jun 3, 2025 | |||
| Garry E. Menzel | Director | Jun 3, 2025 | |||
| Seth Loring Harrison | Director | Jun 3, 2025 | |||
| ATP Life Science Ventures, L.P. | 10%+ Owner | Jun 28, 2021 | |||
| Jennifer Burstein | Director | Jun 3, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|